Organon (OGN) Tops Q2 EPS by 6c ; Offers Guidance

Organon (NYSE: OGN) reported Q2 EPS of $1.00, $0.06 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.27-6.37 billion, versus the consensus of $6.22 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Bain Capital Exited Flash Memory Maker Kioxia, Executive Says - Bloomberg
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook